Elsevier

The Journal of Pediatrics

Volume 107, Issue 3, September 1985, Pages 367-371
The Journal of Pediatrics

Original article
Discontinuation of bee venom immunotherapy in children and adolescents

https://doi.org/10.1016/S0022-3476(85)80508-4Get rights and content

Sixty-six patients with a history of systemic allergy reactions to bee stings, positive skin prick test to ≤100 μg/ml bee venom, and positive radioallergosorbent test (RAST) results were given venom immunotherapy. IgE and IgG antibodies to bee venom were measured by RAST and enzyme-linked immunosorbent test (ELISA), respectively. IgE and IgG anti-bee venom levels rose initially, but subsequently fell during immunotherapy. In 31 patients in whom specific IgE fell to low (less than 6% counts bound) or unmeasurable levels, immunotherapy was discontinued, and sting challenge was carried out 1 to 3 years later. All patients tolerated sting challenge well. The specific IgE and IgG antibody levels did not change significantly after treatment was stopped. Our data suggest that hyposensitization treatment can be stopped when specific IgE serum concentrations have fallen to low or unmeasurable levels and specific IgG antibody values are maintained, and that in a considerable number of patients venom immunotherapy has a lasting therapeutic and immunologic effect.

References (24)

  • KemenyMD et al.

    Antibodies to purified bee venom proteins and peptides. II. A detailed study of chances in IgE and IgG antibodies to individual bee venom proteins

    J Allergy Clin Immunol

    (1983)
  • YungingerJK

    Advances in the diagnosis and treatment of stinging insect allergy

    Pediatrics

    (1981)
  • Cited by (0)

    Supported by Grant Deutsche Forschungsgemeinschaft Ur/12.5.

    View full text